SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading BEAT News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
0.29%43.171.0%$449.60m
MDTMedtronic PLC
-0.94%87.110.8%$432.85m
BSXBoston Scientific Corporation
0.04%23.932.0%$257.46m
ISRGIntuitive Surgical, Inc.
-0.23%689.373.6%$244.33m
TMOThermo Fisher Scientific Inc.
0.43%156.871.3%$236.73m
STJSt. Jude Medical, Inc.
0.16%81.692.0%$199.61m
SYKStryker Corporation
-4.50%117.041.2%$196.33m
ZBHZimmer Biomet Holdings, Inc.
-0.66%124.462.8%$189.21m
BAXBaxter International Inc.
0.46%46.311.9%$184.25m
EWEdwards Lifesciences Corporation
-0.04%106.221.5%$162.98m
BDXBecton, Dickinson and Company
-0.70%173.642.6%$148.14m
BCRC. R. Bard, Inc.
-0.65%229.941.7%$102.71m
XRAYDENTSPLY International Inc.
0.42%62.735.5%$98.41m
HOLXHologic, Inc.
0.19%36.523.9%$95.15m
DXCMDexCom, Inc.
3.85%87.892.5%$90.92m

Company Profile

BioTelemetry, Inc. operates as a wireless medical technology company, which focuses on the delivery of health information. The company provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. It operates through three segments: Patient Services, Product and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its mobile cardiac outpatient telemetry event and holter services. The Product segment focuses on the development, manufacturing, testing and marketing of medical devices to healthcare companies, clinics and hospitals. The Research Services segment focuses on providing cardiac safety monitoring services for drug and medical devices trials in a research environment. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.